Skip to content

Optimization of the Ambulatory Monitoring for Patients With Heart Failure by Tele-cardiology

Optimisation de la Surveillance Ambulatoire Des Insuffisants CArdiaques Par Télécardiologie (OSICAT)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02068118
Acronym
OSICAT
Enrollment
990
Registered
2014-02-21
Start date
2013-05-31
Completion date
2018-09-28
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure

Keywords

E health, Telemonitoring, Prevention, Heart Failure, Cordiva, Telecardiology Program, Remote Patient Management, Education

Brief summary

Targeted population: Patients with heart failure causing hospitalization during the last twelve months. Hypothesis: The number of all cause deaths and hospitalizations will be smaller for the Telecardiology group than for the reference group (standard follow-up care). An 18 months period of observation is required. Main goal: To compare the rate of all cause deaths and hospitalizations of patients with heart failure between the Telecardiology group and the reference group after 18 months of monitoring.

Detailed description

COMPARATIVE STUDY: Comparative study of patients with chronic heart failure, randomized ratio (1:1), with two study arms (telecardiology vs usual care). French multicenter study. The planned enrolment is 990 patients in a total period of 3.5 years. This study will involve an enrolment visit, managed by the recruiting investigator cardiologist, then four telephone contacts by Clinical Studies Technicians (CST). The purpose of the CST telephone contacts is to record the study data, and this will be occur for both study arms. Throughout the study, the patients in the telecardiology study arm will have regular contact with the Cordiva nurses for the management of their chronic heart failure, through telemonitoring and coaching. There is no planned hospitalization for the study. Patients in the control group will receive the usual care: After enrolment, they will return home and will subsequently have regular visits to their General Practitioner (GP) or referring cardiologist. Patients in the telecardiology group will receive the necessary monitoring equipment in their home in the week following their enrolment visit. This equipment includes a connected electronic scale and a questionnaire box. This questionnaire is designed to evaluate the evolution of patient symptoms. During the presentation of the study to the patient before study inclusion, the investigator will inform the patient about the use of the equipment. The material provided is self installable but if the patient asks for help, the equipment will be installed at the patient's home by a private nurse, who also will check that the patient knows how to use the equipment. Each patient will respond daily to 8 yes/no questions: * Did you have more breathing issues last night than the previous night? * Did you need an extra pillow for better breathing last night? * Do you cough more than usual? * Are your legs are more swollen than usual? * Do you feel yourself more tired than usual? * Have you had or do you have a fever above 38.5 °C? * Have you felt or do you feel palpitations? * Do you find that your physical activity is more limited today than the previous days? Patients should simply answer yes or no to all of these questions through the questionnaire box. The self-monitoring parameters (weight and questionnaire answers) will be remotely transmitted via standard phone lines (wired, 3G or GPRS) to the secured servers. These data will be analyzed automatically by an expert system that will generate an alert in case of abnormal values. The objective is to anticipate possible acute cardiac failure. The specialized nurses from the Cordiva center will manage those alerts during working hours and will contact the patient to validate with him the relevance of the alert. If the clinical reality of the alert is confirmed, the nurse will advise the patient to contact his GP or referring cardiologist. In parallel to the nurse advising the patient, the referring physician will receive an alert report including the weight values and the symptoms which triggered this alert. Then, he can then take any action he considers appropriate. A binder will be sent to the patients. This will contain various information related to the management of their heart failure: heart physiology, symptoms, treatments, diet, physical activity... The purpose of this binder is to support the discussion between the Cordiva nurses and the patient. Upon receipt and installation of the equipment in the patient's home, the nurses will arrange a first telephone interview, which will last approximately 45 minutes. The nurses will first introduce the team and the overall clinical approach, and will have a discussion with the patient to better understand the patient (anamnesis, treatment, psycho-social profile, smoking, alcohol use, physical activity, and so on). After this call, patient and nurse will together determine together the date for the next phone call date. On a regular basis (for example every three weeks), a Cordiva nurse will call the patient to check the current status of his disease and its treatment, and to assist him in the management of his disease on a daily basis (compliance, physical activity, nutrition, illness experience... ) . This call will last approx. 15 minutes, however, the duration of the call is not limited, but is defined according to the needs of the patient. At the end of each call, the nurse will define with the patient educational goals (disease knowledge, treatments, recognizing acute episodes symptoms, learning better health habits, practise regular physical activity). Cordiva center is also available for patient's inbound calls. In this way, patients will be able to easily call the center during working hours, and discuss with a specialized Cordiva nurse. This line is not an emergency line and does not replace the 112, which remains the only accredited contact in case of emergencies. In case of temporary travel of the patient away from home (i.e. for holidays), the patient can take the box and scale with him. This material is provided with GPRS SIM card, so the connection will be maintained. The patient may also provide an alternative phone number for the calls with the nurses. The patient's GP will be involved in this outpatient care from the beginning of the study. Indeed, data collected through the connected boxes and scales will be displayed in dedicated reports sent to the GP. These reports will be transmitted every 2 months. These reports will also be sent to the referring cardiologist if requested. Moreover, in case of validated alerts, the referring physician will have access to a weight and symptoms report, allowing him to take any action he thinks appropriate. ABOUT CORDIVA CENTER: The center has a team of specialized and graduated nurses in heart failure management and in therapeutic education, due to the dedicated training they have received. Indeed, many studies in the multidisciplinary care of heart failure patients have demonstrated the key role of nurses, acting as bridge between patients and health professionals. The nurses take care of patient compliance based on the referring cardiologist or general practitioner instructions, and monitor patient clinical parameters (weight and symptoms). The nurses use a software based interviews guide. Patient objectives are defined based on information regarding certain factors (health status, clinical signs, drugs), and this information will be collected by the nurses into a computerized database. This information is requested in strict patient accompanying perspective and therefore do not appear in the study results. The two data sets (data collected by nurses for patient management on one hand, and data collected by CST for the study on another hand) will never be connected and only study data from CST will be used to assess study criteria. To evaluate patient knowledge and needs, the nurses use active listening (open questions, paraphrasing, empathy and positive reinforcement). These techniques help them to customize information and messages and reinforce personalized care. Cordiva center nurses benefit from specialized training in motivational interviewing. They have also received dedicated training in cardiology and heart failure, mental state of heart failure patients, communication and patient education. Coherence of this informative approach is guaranteed on one hand because of the tools available for the nurses (binder, interview guide), and on the other hand because of the center organization itself: monitoring of patients insured by team of nurses, weekly debrief of recorded calls… EXTENSION PERIOD: The extension period will be conducted on an open, non-comparative basis. The aim of the extension period is to allow patients who wish to do so to follow the telemonitoring program until its marketing, regardless of the randomization group on initial inclusion in the study.

Interventions

DEVICETelecardiology program

The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses. Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.

Sponsors

CDM e-Health
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 18 years or older * Men or women patient with heart failure having been hospitalized for cardiac decompensation during the last 12 months. * Patient with access to a wireline telephone service or GPRS network. * The patient is willing and able to sign an informed written consent * Patient is insured under the social security system

Exclusion criteria

* No available echocardiographic evaluation. * BNP lower than 100pg/ml or NT-proBNP lower than 300pg/ml * A prognosis of a life span of less than 12 months (apart from heart failure) * Dialysis patients * Heart transplant or cardiac assist devices * Patients involved in inotropic treatment * Patient doesn't have the necessary autonomy to use the equipment * Patient enrolled in another clinical trial * A pregnant or nursing woman, or patient of reproductive age who doesn't use contraceptives * Patients under tutorship, curatorship or judicial protection Inclusion Criteria in the extension period: Participation in the open extension period is only offered to patients who participated in the comparative period of the study, did not withdraw prematurely from the latter and gave their free informed written consent to participate to the extension period.

Design outcomes

Primary

MeasureTime frameDescription
Number of All Causes Deaths and (Unplanned) Hospitalizations18 monthsComposite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)
Number of All Causes Deaths and (Unplanned) Hospitalizations in NYHA Class III or IV Patients18 monthsComposite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)
Number of All Causes Deaths and (Unplanned) Hospitalizations in Socially Isolated Patients18 monthsComposite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)

Secondary

MeasureTime frameDescription
Number of Unplanned Hospitalizations for Any Cause18 monthsNumber of unplanned hospitalizations for any cause (adjudicated events)
Number of Deaths and Unplanned Hospitalizations From Cardiovascular Cause18 monthsComposite morbidity-mortality criterion combining the number of cardiovascular unplanned hospitalizations and deaths from cardiovascular cause (adjudicated events)
Number of Unplanned Hospitalizations for Heart Failure18 monthsNumber of unplanned hospitalizations for heart failure (adjudicated events)
Number of Unplanned Hospitalizations for Heart Failure in NYHA Class III or IV Patients18 monthsNumber of unplanned hospitalizations for heart failure (adjudicated events)
Number of Unplanned Hospitalizations for Heart Failure in Socially Isolated Patients18 monthsNumber of unplanned hospitalizations for heart failure (adjudicated events)
Time to First Unplanned Hospital Readmission or Death From Any Cause18 monthsTime to first unplanned hospital readmission (adjudicated events) or death from any cause, whichever occurred first in the subgroup of patients concerned
Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresBetween baseline and 12 months and between baseline and 18 monthsEvolution of Quality of Life assessed using absolute changes from baseline of each dimension and both component summary scores of SF-36 questionnaire. Indeed, SF-36 questionnaire include 8 general dimensions and 2 composite scores: the Physical Component Summary (PCS) and the Mental Component Summary (MCS). They are standardized to range between 0 and 100. Higher scores on all SF-36 scales indicate more favorable levels of functioning and less disability. Thus, higher Physical Functioning scores reflect higher physical functioning. Higher Role Physical scores reflect lower limitations due to physical problems. Higher Bodily Pain scores reflect less bodily pain. Higher General Health scores reflect higher general health perception. Higher Vitality scores reflect higher vitality. Higher Social Functioning scores reflect higher social functioning. Higher Role Emotional scores reflect lower limitations due to emotional problems. Higher Mental Health scores reflect better mental health.
Annualized Number of Unplanned Hospitalizations for Any Cause During the Extension PeriodExtension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)Annualized number of unplanned hospitalizations for any cause according to investigators in patients hospitalized at least once during the extension period
Number of Patients Who Died From Any Cause During the Extension PeriodExtension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)Number of patients who died from any cause during the extension period
Annualized Number of Unplanned Hospitalizations From Cardiovascular Cause During the Extension PeriodExtension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)Annualized number of unplanned hospitalizations from cardiovascular cause according to investigators in patients hospitalized at least once for cardiovascular cause during the extension period
Number of Patients Who Died From Cardiovascular Cause During the Extension PeriodExtension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)Number of patients who died from cardiovascular cause according to investigators during the extension period
Time to First Unplanned Hospital Readmission for Heart Failure18 monthsTime to first unplanned hospital readmission for heart failure (adjudicated events) in the subgroup of patients concerned
All Causes Deaths - Number of Patients Who Died From Any Cause18 monthsNumber of patients who died from any cause
Time to Death From Any Cause18 monthsTime to death from any cause in the subgroup of patients who died

Countries

France, Martinique

Participant flow

Recruitment details

Between May 13, 2013 and June 22, 2016, 990 patients were enrolled at 38 French centers. Last patient completed 18-month comparative period on December 20, 2017. After this 18-month period, 20 patients entered the non-comparative extension period between June 1, 2017 and March 27, 2018. Last patient completed extension period on September 28, 2018.

Participants by arm

ArmCount
Standard Care
Standard follow-up, with conventional monitoring involving consultations and monitoring by their general practitioners or referring cardiologists
455
Tele-cardiology Group
The telecardiology program is a combination of a scale, a device asking the patients questions about the symptoms associated with their heart failure, and regular phone calls made by nurses. Automatic algorithms have been built-up in order to detect early the need for a hospitalization due to heart failure.
482
Total937

Withdrawals & dropouts

PeriodReasonFG000FG001
18-month Comparative Study PeriodAlzheimer's disease01
18-month Comparative Study PeriodDeath9097
18-month Comparative Study PeriodHearing loss01
18-month Comparative Study PeriodHeart transplant915
18-month Comparative Study PeriodHemiplegia01
18-month Comparative Study PeriodInclusion in another protocol02
18-month Comparative Study PeriodLost to Follow-up67
18-month Comparative Study PeriodMove01
18-month Comparative Study PeriodWithdrawal by Subject2352
Extension PeriodDeath02
Extension PeriodHeart transplant10
Extension PeriodWithdrawal by Subject10
Extension PeriodWrong device use01

Baseline characteristics

CharacteristicTotalStandard CareTele-cardiology Group
ACE inhibitors or ARBs
No
238 Participants110 Participants128 Participants
ACE inhibitors or ARBs
Yes
699 Participants345 Participants354 Participants
Age, Continuous69.9 years
STANDARD_DEVIATION 12.4
69.7 years
STANDARD_DEVIATION 12.5
70.0 years
STANDARD_DEVIATION 12.4
Age, Customized
≥ 60 and < 80 years
505 Participants237 Participants268 Participants
Age, Customized
< 60 years
198 Participants105 Participants93 Participants
Age, Customized
≥ 80 years
234 Participants113 Participants121 Participants
Aldosterone antagonists
No
506 Participants244 Participants262 Participants
Aldosterone antagonists
Yes
431 Participants211 Participants220 Participants
Arterial hypertension
No
395 Participants209 Participants186 Participants
Arterial hypertension
Yes
542 Participants246 Participants296 Participants
Beta-blockers
No
191 Participants88 Participants103 Participants
Beta-blockers
Yes
746 Participants367 Participants379 Participants
BNP501 pg/mL484 pg/mL510 pg/mL
Body Mass Index (BMI)27.4 kg/m²
STANDARD_DEVIATION 5.8
27.1 kg/m²
STANDARD_DEVIATION 5.5
27.6 kg/m²
STANDARD_DEVIATION 6
Cardiac resynchronization therapy
No
936 Participants454 Participants482 Participants
Cardiac resynchronization therapy
Yes
1 Participants1 Participants0 Participants
Cardiopathy
Ischemic
443 Participants211 Participants232 Participants
Cardiopathy
Non Ischemic
492 Participants243 Participants249 Participants
Chronic Obstructive Pulmonary Disease
No
759 Participants366 Participants393 Participants
Chronic Obstructive Pulmonary Disease
Yes
178 Participants89 Participants89 Participants
Chronic renal disease
No
679 Participants327 Participants352 Participants
Chronic renal disease
Yes
257 Participants128 Participants129 Participants
Coronary heart disease
No
473 Participants227 Participants246 Participants
Coronary heart disease
Yes
464 Participants228 Participants236 Participants
Diabetes mellitus
No
630 Participants294 Participants336 Participants
Diabetes mellitus
Yes
307 Participants161 Participants146 Participants
Digoxin
No
892 Participants439 Participants453 Participants
Digoxin
Yes
43 Participants15 Participants28 Participants
Dyslipidemia
No
420 Participants207 Participants213 Participants
Dyslipidemia
Yes
517 Participants248 Participants269 Participants
Family History of Cardiovascular Disease
No
755 Participants382 Participants373 Participants
Family History of Cardiovascular Disease
Yes
182 Participants73 Participants109 Participants
Glomerular Filtration Rate (GFR)60.5 mL/min
STANDARD_DEVIATION 25.3
60.6 mL/min
STANDARD_DEVIATION 25.1
60.5 mL/min
STANDARD_DEVIATION 25.5
Heart failure
Global
506 Participants235 Participants271 Participants
Heart failure
Left
369 Participants184 Participants185 Participants
Heart failure
Right
58 Participants34 Participants24 Participants
Implantable cardioverter-defibrillator
No
817 Participants395 Participants422 Participants
Implantable cardioverter-defibrillator
Yes
120 Participants60 Participants60 Participants
Ivabradine
No
872 Participants416 Participants456 Participants
Ivabradine
Yes
60 Participants37 Participants23 Participants
Left Ventricular Ejection Fraction (LVEF)38.7 Percentage
STANDARD_DEVIATION 14.9
38.1 Percentage
STANDARD_DEVIATION 15.2
39.3 Percentage
STANDARD_DEVIATION 14.5
Left Ventricular Ejection Fraction (LVEF), categorical
≤ 40%
560 Participants280 Participants280 Participants
Left Ventricular Ejection Fraction (LVEF), categorical
> 40% and ≤ 50%
184 Participants89 Participants95 Participants
Left Ventricular Ejection Fraction (LVEF), categorical
> 50%
190 Participants86 Participants104 Participants
Loop diuretics
No
73 Participants38 Participants35 Participants
Loop diuretics
Yes
864 Participants417 Participants447 Participants
NT-pro-BNP3379 pg/mL3277 pg/mL3519 pg/mL
NYHA classification
I
61 Participants32 Participants29 Participants
NYHA classification
II
406 Participants196 Participants210 Participants
NYHA classification
III
367 Participants185 Participants182 Participants
NYHA classification
IV
93 Participants39 Participants54 Participants
Obesity
No
675 Participants333 Participants342 Participants
Obesity
Yes
262 Participants122 Participants140 Participants
Previous participation in an ETP
No
714 Participants341 Participants373 Participants
Previous participation in an ETP
Yes
223 Participants114 Participants109 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
France
937 Participants455 Participants482 Participants
Sex: Female, Male
Female
260 Participants132 Participants128 Participants
Sex: Female, Male
Male
677 Participants323 Participants354 Participants
Smoking
No
710 Participants339 Participants371 Participants
Smoking
Yes
227 Participants116 Participants111 Participants
Supine diastolic blood pressure69.7 mmHg
STANDARD_DEVIATION 11.7
69.5 mmHg
STANDARD_DEVIATION 12.2
69.9 mmHg
STANDARD_DEVIATION 11.2
Supine pulse rate73.2 beats/min
STANDARD_DEVIATION 14.7
72.7 beats/min
STANDARD_DEVIATION 13.9
73.7 beats/min
STANDARD_DEVIATION 15.4
Supine systolic blood pressure119.3 mmHg
STANDARD_DEVIATION 19.6
118.9 mmHg
STANDARD_DEVIATION 19.3
119.6 mmHg
STANDARD_DEVIATION 19.9
Weight78.3 kg
STANDARD_DEVIATION 18
77.2 kg
STANDARD_DEVIATION 17.8
79.3 kg
STANDARD_DEVIATION 18.2

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
90 / 45599 / 482
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Number of All Causes Deaths and (Unplanned) Hospitalizations

Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)

Time frame: 18 months

Population: ITT population

ArmMeasureValue (MEAN)Dispersion
Standard CareNumber of All Causes Deaths and (Unplanned) Hospitalizations1.46 EventsStandard Deviation 1.98
Tele-cardiology GroupNumber of All Causes Deaths and (Unplanned) Hospitalizations1.30 EventsStandard Deviation 1.85
Comparison: Number of events compared using a negative binomial regression model with log link for the expected rate of events (i.e., number of events divided by the effective duration of follow-up).~Deaths that occurred during hospitalization with an overnight stay were counted as two events.p-value: =0.895% CI: [0.77, 1.23]negative binomial regression
Primary

Number of All Causes Deaths and (Unplanned) Hospitalizations in NYHA Class III or IV Patients

Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)

Time frame: 18 months

Population: ITT population with New York Heart Association (NYHA) class III or IV at inclusion (N=460 patients)

ArmMeasureValue (MEAN)Dispersion
Standard CareNumber of All Causes Deaths and (Unplanned) Hospitalizations in NYHA Class III or IV Patients1.99 EventsStandard Deviation 2.26
Tele-cardiology GroupNumber of All Causes Deaths and (Unplanned) Hospitalizations in NYHA Class III or IV Patients1.53 EventsStandard Deviation 1.98
Comparison: Number of events compared using a negative binomial regression model with log link for the expected rate of events (i.e., number of events divided by the effective duration of follow-up).~Deaths that occurred during hospitalization with an overnight stay were counted as two events.p-value: =0.1895% CI: [0.62, 1.1]negative binomial regression
Primary

Number of All Causes Deaths and (Unplanned) Hospitalizations in Socially Isolated Patients

Composite morbidity-mortality criterion combining the number of unplanned hospitalizations for any cause and deaths from any cause (adjudicated events)

Time frame: 18 months

Population: ITT population with socially isolated status at inclusion (N=216 patients) defined as: either i) SF-36 Mental Health score \<45; or ii) Mental Component Summary score \<35; or iii) combination of Mental Health score \<50 plus Mental Component Summary score \<40; or iv) medical history of depression or mood disorders/alterations; or v) use of concomitant antidepressant medications

ArmMeasureValue (MEAN)Dispersion
Standard CareNumber of All Causes Deaths and (Unplanned) Hospitalizations in Socially Isolated Patients1.89 EventsStandard Deviation 2.14
Tele-cardiology GroupNumber of All Causes Deaths and (Unplanned) Hospitalizations in Socially Isolated Patients1.30 EventsStandard Deviation 1.66
Comparison: Number of events compared using a negative binomial regression model with log link for the expected rate of events (i.e., number of events divided by the effective duration of follow-up).~Deaths that occurred during hospitalization with an overnight stay were counted as two events.p-value: =0.0295% CI: [0.39, 0.92]negative binomial regression
Secondary

All Causes Deaths - Number of Patients Who Died From Any Cause

Number of patients who died from any cause

Time frame: 18 months

Population: ITT population

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard CareAll Causes Deaths - Number of Patients Who Died From Any Cause89 Participants
Tele-cardiology GroupAll Causes Deaths - Number of Patients Who Died From Any Cause91 Participants
Secondary

Annualized Number of Unplanned Hospitalizations for Any Cause During the Extension Period

Annualized number of unplanned hospitalizations for any cause according to investigators in patients hospitalized at least once during the extension period

Time frame: Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)

Population: Extension Period Set

ArmMeasureValue (MEAN)Dispersion
Standard CareAnnualized Number of Unplanned Hospitalizations for Any Cause During the Extension Period1.30 EventsStandard Deviation 0.57
Tele-cardiology GroupAnnualized Number of Unplanned Hospitalizations for Any Cause During the Extension Period3.30 EventsStandard Deviation 2.09
Secondary

Annualized Number of Unplanned Hospitalizations From Cardiovascular Cause During the Extension Period

Annualized number of unplanned hospitalizations from cardiovascular cause according to investigators in patients hospitalized at least once for cardiovascular cause during the extension period

Time frame: Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)

Population: Extension Period Set

ArmMeasureValue (MEAN)Dispersion
Standard CareAnnualized Number of Unplanned Hospitalizations From Cardiovascular Cause During the Extension Period1.30 EventsStandard Deviation 0.57
Tele-cardiology GroupAnnualized Number of Unplanned Hospitalizations From Cardiovascular Cause During the Extension Period2.84 EventsStandard Deviation 1.18
Secondary

Evolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire Scores

Evolution of Quality of Life assessed using absolute changes from baseline of each dimension and both component summary scores of SF-36 questionnaire. Indeed, SF-36 questionnaire include 8 general dimensions and 2 composite scores: the Physical Component Summary (PCS) and the Mental Component Summary (MCS). They are standardized to range between 0 and 100. Higher scores on all SF-36 scales indicate more favorable levels of functioning and less disability. Thus, higher Physical Functioning scores reflect higher physical functioning. Higher Role Physical scores reflect lower limitations due to physical problems. Higher Bodily Pain scores reflect less bodily pain. Higher General Health scores reflect higher general health perception. Higher Vitality scores reflect higher vitality. Higher Social Functioning scores reflect higher social functioning. Higher Role Emotional scores reflect lower limitations due to emotional problems. Higher Mental Health scores reflect better mental health.

Time frame: Between baseline and 12 months and between baseline and 18 months

Population: ITT population

ArmMeasureGroupValue (MEAN)Dispersion
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresMental Component Summary - 18 Months2.0 score on a scaleStandard Deviation 10.4
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresGeneral Health - 18 Months5.2 score on a scaleStandard Deviation 20.4
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresVitality - 12 Months5.7 score on a scaleStandard Deviation 22.1
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresVitality - 18 Months7.3 score on a scaleStandard Deviation 21.7
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresRole Emotional - 12 Months-4.3 score on a scaleStandard Deviation 45.7
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresRole Emotional - 18 Months6.0 score on a scaleStandard Deviation 35.8
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresPhysical Functioning - 12 months-1.3 score on a scaleStandard Deviation 27.3
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresPhysical Functioning - 18 months2.4 score on a scaleStandard Deviation 26.3
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresRole Physical - 12 Months12.5 score on a scaleStandard Deviation 48
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresRole Physical - 18 Months20.5 score on a scaleStandard Deviation 40.2
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresSocial Functioning - 18 Months3.2 score on a scaleStandard Deviation 33.3
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresBodily Pain - 18 Months0.6 score on a scaleStandard Deviation 35.8
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresBodily Pain - 12 Months1.9 score on a scaleStandard Deviation 38.8
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresGeneral Health - 12 Months0.4 score on a scaleStandard Deviation 21.7
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresMental Health - 18 Months3.3 score on a scaleStandard Deviation 18.9
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresMental Health - 12 Months1.6 score on a scaleStandard Deviation 19.4
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresPhysical Component Summary - 12 Months1.5 score on a scaleStandard Deviation 11.2
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresPhysical Component Summary - 18 Months2.9 score on a scaleStandard Deviation 10.6
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresMental Component Summary - 12 Months0.1 score on a scaleStandard Deviation 10.8
Standard CareEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresSocial Functioning - 12 Months-0.3 score on a scaleStandard Deviation 35.5
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresMental Health - 18 Months4.3 score on a scaleStandard Deviation 18.5
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresSocial Functioning - 12 Months4.4 score on a scaleStandard Deviation 33.8
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresMental Component Summary - 18 Months3.1 score on a scaleStandard Deviation 10.4
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresSocial Functioning - 18 Months3.8 score on a scaleStandard Deviation 33.9
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresVitality - 12 Months9.0 score on a scaleStandard Deviation 23.7
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresBodily Pain - 18 Months4.6 score on a scaleStandard Deviation 33.6
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresVitality - 18 Months11.1 score on a scaleStandard Deviation 21.8
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresPhysical Component Summary - 12 Months2.2 score on a scaleStandard Deviation 11.1
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresRole Emotional - 12 Months-2.7 score on a scaleStandard Deviation 46.9
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresGeneral Health - 12 Months3.4 score on a scaleStandard Deviation 22.3
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresGeneral Health - 18 Months6.8 score on a scaleStandard Deviation 22.5
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresPhysical Functioning - 12 months0.0 score on a scaleStandard Deviation 28
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresMental Component Summary - 12 Months1.8 score on a scaleStandard Deviation 11.3
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresPhysical Functioning - 18 months1.3 score on a scaleStandard Deviation 28.3
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresRole Emotional - 18 Months8.3 score on a scaleStandard Deviation 35.9
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresPhysical Component Summary - 18 Months3.2 score on a scaleStandard Deviation 10.7
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresRole Physical - 12 Months12.5 score on a scaleStandard Deviation 48
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresRole Physical - 18 Months20.7 score on a scaleStandard Deviation 41.1
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresMental Health - 12 Months3.9 score on a scaleStandard Deviation 18.8
Tele-cardiology GroupEvolution of Quality of Life Assessed by Short Form-36 (SF-36) Questionnaire ScoresBodily Pain - 12 Months4.1 score on a scaleStandard Deviation 36.9
Comparison: ANCOVA Physical Functioning score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with physical functioning score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factorp-value: =0.1795% CI: [-2.48, 4.61]Mixed Models Analysis
Comparison: ANCOVA Role Physical score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with role physical score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factorp-value: =0.2395% CI: [-2.61, 6.21]Mixed Models Analysis
Comparison: ANCOVA Bodily Pain score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with bodily pain score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factorp-value: =0.595% CI: [0.59, 8.33]Mixed Models Analysis
Comparison: ANCOVA General Health score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with general health score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factorp-value: =0.1995% CI: [-0.07, 5.12]Mixed Models Analysis
Comparison: ANCOVA Vitality score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with vitality score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factorp-value: =0.03495% CI: [-0.09, 4.85]Mixed Models Analysis
Comparison: ANCOVA Social Functioning score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with social functioning score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factorp-value: =0.02595% CI: [0.6, 7.47]Mixed Models Analysis
Comparison: ANCOVA Role Emotional score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with role emotional score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factorp-value: =0.995% CI: [-2.79, 4.81]Mixed Models Analysis
Comparison: ANCOVA Mental Health score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with mental health score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factorp-value: =0.1995% CI: [0.16, 4.37]Mixed Models Analysis
Comparison: ANCOVA Physical Component Summary (PCS) score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with PCS score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factorp-value: =0.2695% CI: [-0.48, 2.28]Mixed Models Analysis
Comparison: ANCOVA Mental Component Summary (MCS) score: Parametric analysis of covariance mixed model on repeated measurements (Baseline, 12 and 18 months) with MCS score assessed at baseline as covariate, study group and visit as fixed factors, interaction between study group and visit, interaction between study group and score assessed at baseline and patient as random factorp-value: =0.1795% CI: [0.08, 2.31]Mixed Models Analysis
Secondary

Number of Deaths and Unplanned Hospitalizations From Cardiovascular Cause

Composite morbidity-mortality criterion combining the number of cardiovascular unplanned hospitalizations and deaths from cardiovascular cause (adjudicated events)

Time frame: 18 months

Population: ITT population

ArmMeasureValue (MEAN)Dispersion
Standard CareNumber of Deaths and Unplanned Hospitalizations From Cardiovascular Cause1.07 EventsStandard Deviation 1.75
Tele-cardiology GroupNumber of Deaths and Unplanned Hospitalizations From Cardiovascular Cause0.96 EventsStandard Deviation 1.56
Comparison: Number of events compared using a negative binomial regression model with log link for the expected rate of events (i.e., number of events divided by the effective duration of follow-up).~Deaths from cardiovascular cause that occurred during a hospitalization for cardiovascular cause with an overnight stay were counted as two events.p-value: =0.8395% CI: [0.74, 1.27]negative binomial regression
Secondary

Number of Patients Who Died From Any Cause During the Extension Period

Number of patients who died from any cause during the extension period

Time frame: Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)

Population: Extension Period Set

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard CareNumber of Patients Who Died From Any Cause During the Extension Period0 Participants
Tele-cardiology GroupNumber of Patients Who Died From Any Cause During the Extension Period2 Participants
Secondary

Number of Patients Who Died From Cardiovascular Cause During the Extension Period

Number of patients who died from cardiovascular cause according to investigators during the extension period

Time frame: Extension period until the marketing of the telemonitoring program (from 2 to 16 months, with an average of 9.5 months)

Population: Extension Period Set

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard CareNumber of Patients Who Died From Cardiovascular Cause During the Extension Period0 Participants
Tele-cardiology GroupNumber of Patients Who Died From Cardiovascular Cause During the Extension Period0 Participants
Secondary

Number of Unplanned Hospitalizations for Any Cause

Number of unplanned hospitalizations for any cause (adjudicated events)

Time frame: 18 months

Population: ITT population

ArmMeasureValue (MEAN)Dispersion
Standard CareNumber of Unplanned Hospitalizations for Any Cause1.27 EventsStandard Deviation 1.82
Tele-cardiology GroupNumber of Unplanned Hospitalizations for Any Cause1.11 EventsStandard Deviation 1.67
Comparison: Number of events compared using a negative binomial regression model with log link for the expected rate of events (i.e., number of events divided by the effective duration of follow-up).p-value: =0.7795% CI: [0.78, 1.21]negative binomial regression
Secondary

Number of Unplanned Hospitalizations for Heart Failure

Number of unplanned hospitalizations for heart failure (adjudicated events)

Time frame: 18 months

Population: ITT population

ArmMeasureValue (MEAN)Dispersion
Standard CareNumber of Unplanned Hospitalizations for Heart Failure0.75 EventsStandard Deviation 1.42
Tele-cardiology GroupNumber of Unplanned Hospitalizations for Heart Failure0.59 EventsStandard Deviation 1.26
Comparison: Number of events compared using a negative binomial regression model with log link for the expected rate of events (i.e., number of events divided by the effective duration of follow-up)p-value: =0.2895% CI: [0.62, 1.15]negative binomial regression
Secondary

Number of Unplanned Hospitalizations for Heart Failure in NYHA Class III or IV Patients

Number of unplanned hospitalizations for heart failure (adjudicated events)

Time frame: 18 months

Population: ITT population with New York Heart Association (NYHA) class III or IV at inclusion (N=460 patients)

ArmMeasureValue (MEAN)Dispersion
Standard CareNumber of Unplanned Hospitalizations for Heart Failure in NYHA Class III or IV Patients1.02 EventsStandard Deviation 1.68
Tele-cardiology GroupNumber of Unplanned Hospitalizations for Heart Failure in NYHA Class III or IV Patients0.70 EventsStandard Deviation 1.36
Comparison: Number of events compared using a negative binomial regression model with log link for the expected rate of events (i.e., number of events divided by the effective duration of follow-up)p-value: =0.07895% CI: [0.48, 1.04]negative binomial regression
Secondary

Number of Unplanned Hospitalizations for Heart Failure in Socially Isolated Patients

Number of unplanned hospitalizations for heart failure (adjudicated events)

Time frame: 18 months

Population: ITT population with socially isolated status at inclusion (N=216 patients) defined as: either i) SF-36 Mental Health score \<45; or ii) Mental Component Summary score \<35; or iii) combination of Mental Health score \<50 plus Mental Component Summary score \<40; or iv) medical history of depression or mood disorders/alterations; or v) use of concomitant antidepressant medications

ArmMeasureValue (MEAN)Dispersion
Standard CareNumber of Unplanned Hospitalizations for Heart Failure in Socially Isolated Patients1.00 EventsStandard Deviation 1.61
Tele-cardiology GroupNumber of Unplanned Hospitalizations for Heart Failure in Socially Isolated Patients0.58 EventsStandard Deviation 1.15
Comparison: Number of events compared using a negative binomial regression model with log link for the expected rate of events (i.e., number of events divided by the effective duration of follow-up)p-value: =0.02395% CI: [0.28, 0.91]negative binomial regression
Secondary

Time to Death From Any Cause

Time to death from any cause in the subgroup of patients who died

Time frame: 18 months

Population: ITT population

ArmMeasureValue (MEDIAN)
Standard CareTime to Death From Any Cause233 days
Tele-cardiology GroupTime to Death From Any Cause252 days
Comparison: Time to death from any cause compared using the log-rank testp-value: =0.85Log Rank
Secondary

Time to First Unplanned Hospital Readmission for Heart Failure

Time to first unplanned hospital readmission for heart failure (adjudicated events) in the subgroup of patients concerned

Time frame: 18 months

Population: ITT population

ArmMeasureValue (MEDIAN)
Standard CareTime to First Unplanned Hospital Readmission for Heart Failure79 days
Tele-cardiology GroupTime to First Unplanned Hospital Readmission for Heart Failure97 days
Comparison: Time to first unplanned hospital readmission for heart failure compared using multivariable Cox regression modelp-value: =0.04495% CI: [0.62, 0.99]Regression, Cox
Secondary

Time to First Unplanned Hospital Readmission or Death From Any Cause

Time to first unplanned hospital readmission (adjudicated events) or death from any cause, whichever occurred first in the subgroup of patients concerned

Time frame: 18 months

Population: ITT population

ArmMeasureValue (MEDIAN)
Standard CareTime to First Unplanned Hospital Readmission or Death From Any Cause84 days
Tele-cardiology GroupTime to First Unplanned Hospital Readmission or Death From Any Cause105 days
Comparison: Time to first event compared using the log-rank testp-value: =0.68Log Rank
Post Hoc

Time to First Unplanned Hospital Readmission for Heart Failure in NYHA Class III or IV Patients

Time to first unplanned hospital readmission for heart failure (adjudicated events) in the subgroup of patients concerned

Time frame: 18 months

Population: New York Heart Association (NYHA) class III or IV at inclusion patients with unplanned hospital readmission for heart failure included in the Overall Number of Participants Analyzed

ArmMeasureValue (MEDIAN)
Standard CareTime to First Unplanned Hospital Readmission for Heart Failure in NYHA Class III or IV Patients62 days
Tele-cardiology GroupTime to First Unplanned Hospital Readmission for Heart Failure in NYHA Class III or IV Patients82 days
Comparison: Time to first unplanned hospital readmission for heart failure compared using multivariable Cox regression modelp-value: =0.0295% CI: [0.53, 0.95]Regression, Cox
Post Hoc

Time to First Unplanned Hospital Readmission for Heart Failure in Socially Isolated Patients

Time to first unplanned hospital readmission for heart failure (adjudicated events) in the subgroup of patients concerned

Time frame: 18 months

Population: Patients with socially isolated status at inclusion defined as: either i) SF-36 Mental Health score \<45; or ii) Mental Component Summary score \<35; or iii) combination of Mental Health score \<50 plus Mental Component Summary score \<40; or iv) medical history of depression or mood disorders/alterations; or v) use of concomitant antidepressant medications and with unplanned hospital readmission for heart failure included in the Overall Number of Participants Analyzed'

ArmMeasureValue (MEDIAN)
Standard CareTime to First Unplanned Hospital Readmission for Heart Failure in Socially Isolated Patients77 days
Tele-cardiology GroupTime to First Unplanned Hospital Readmission for Heart Failure in Socially Isolated Patients80 days
Comparison: Time to first unplanned hospital readmission for heart failure compared using multivariable Cox regression modelp-value: =0.04395% CI: [0.39, 0.98]Regression, Cox
Post Hoc

Time to First Unplanned Hospital Readmission or Death From Any Cause in NYHA Class III or IV Patients

Time to first unplanned hospital readmission (adjudicated events) or death from any cause, whichever occurred first in the subgroup of patients concerned

Time frame: 18 months

Population: New York Heart Association (NYHA) class III or IV at inclusion patients with unplanned hospital readmission or death from any cause included in the Overall Number of Participants Analyzed

ArmMeasureValue (MEDIAN)
Standard CareTime to First Unplanned Hospital Readmission or Death From Any Cause in NYHA Class III or IV Patients67 days
Tele-cardiology GroupTime to First Unplanned Hospital Readmission or Death From Any Cause in NYHA Class III or IV Patients82 days
Comparison: Time to first event compared using the log-rank testp-value: =0.03Log Rank
Post Hoc

Time to First Unplanned Hospital Readmission or Death From Any Cause in Socially Isolated Patients

Time to first unplanned hospital readmission (adjudicated events) or death from any cause, whichever occurred first in the subgroup of patients concerned

Time frame: 18 months

Population: Patients with socially isolated status at inclusion defined as: either i) SF-36 Mental Health score \<45; or ii) Mental Component Summary score \<35; or iii) combination of Mental Health score \<50 plus Mental Component Summary score \<40; or iv) medical history of depression or mood disorders/alterations; or v) use of concomitant antidepressant medications and with unplanned hospital readmission or death from any cause included in the Overall Number of Participants Analyzed'

ArmMeasureValue (MEDIAN)
Standard CareTime to First Unplanned Hospital Readmission or Death From Any Cause in Socially Isolated Patients81 days
Tele-cardiology GroupTime to First Unplanned Hospital Readmission or Death From Any Cause in Socially Isolated Patients91 days
Comparison: Time to first event compared using the log-rank testp-value: =0.15Log Rank

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026